Are Investors Undervaluing AddLife AB (publ) (STO:ALIF B) By 42%?
Apr 22
Swedish (OMX) Clinical Research and Equipment Industry Analysis
UpdatedApr 22, 2024
DataAggregated Company Financials
Companies13
- 7D-4.3%
- 3M-1.4%
- 1Y6.8%
- YTDn/a
Over the last 7 days, the Clinical Research and Equipment industry has dropped 4.3%, driven by a pullback from Biotage of 7.3%. On the other hand BICO Group is actually up 9.7%. Over the past 12 months, the industry was up 6.8%. Looking forward, earnings are forecast to grow by 37% annually.
Industry Valuation and Performance
Has the Swedish Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 24 Apr 2024 | kr36.6b | kr16.0b | -kr1,122,732,213.00 | 34.3x | -32.6x | 2.3x |
| Fri, 22 Mar 2024 | kr39.4b | kr16.0b | -kr1,122,792,210.00 | 36.3x | -35.1x | 2.5x |
| Sun, 18 Feb 2024 | kr41.0b | kr16.0b | -kr1,409,735,350.00 | 50.7x | -29.1x | 2.6x |
| Tue, 16 Jan 2024 | kr37.0b | kr15.5b | -kr1,393,723,683.00 | 44.9x | -26.5x | 2.4x |
| Thu, 14 Dec 2023 | kr35.1b | kr15.5b | -kr1,393,723,683.00 | 42.4x | -25.2x | 2.3x |
| Sat, 11 Nov 2023 | kr31.2b | kr15.4b | -kr1,256,647,710.00 | 34x | -24.8x | 2x |
| Mon, 09 Oct 2023 | kr26.1b | kr15.1b | -kr1,134,516,711.00 | 36.2x | -23x | 1.7x |
| Wed, 06 Sep 2023 | kr30.0b | kr15.1b | -kr1,134,263,831.00 | 41x | -26.4x | 2x |
| Fri, 04 Aug 2023 | kr31.9b | kr15.1b | -kr213,871,038.00 | 46.3x | -149x | 2.1x |
| Sun, 02 Jul 2023 | kr36.5b | kr14.6b | -kr172,476,038.00 | 36.1x | -211.7x | 2.5x |
| Tue, 30 May 2023 | kr39.0b | kr14.6b | -kr173,602,038.00 | 38.3x | -224.7x | 2.7x |
| Thu, 27 Apr 2023 | kr33.7b | kr14.6b | -kr59,425,459.00 | 33.8x | -567.4x | 2.3x |
| Sat, 25 Mar 2023 | kr31.9b | kr14.6b | -kr57,185,459.00 | 31x | -557.6x | 2.2x |
| Mon, 20 Feb 2023 | kr41.4b | kr14.5b | kr826.0m | 36.2x | 50.2x | 2.9x |
| Wed, 18 Jan 2023 | kr41.1b | kr14.2b | kr943.9m | 40.7x | 43.6x | 2.9x |
| Fri, 16 Dec 2022 | kr40.4b | kr14.1b | kr944.3m | 42.4x | 42.7x | 2.9x |
| Sun, 13 Nov 2022 | kr40.0b | kr14.1b | kr936.8m | 42.1x | 42.7x | 2.8x |
| Tue, 11 Oct 2022 | kr32.5b | kr13.5b | kr750.9m | 47.6x | 43.2x | 2.4x |
| Thu, 08 Sep 2022 | kr36.9b | kr13.5b | kr751.3m | 53.1x | 49.2x | 2.7x |
| Sat, 06 Aug 2022 | kr43.7b | kr13.2b | kr667.8m | 44.6x | 65.4x | 3.3x |
| Mon, 04 Jul 2022 | kr44.2b | kr13.2b | kr753.4m | 39.4x | 58.7x | 3.3x |
| Wed, 01 Jun 2022 | kr58.4b | kr13.2b | kr753.4m | 51x | 77.5x | 4.4x |
| Fri, 29 Apr 2022 | kr52.3b | kr11.9b | kr743.5m | 51.3x | 70.3x | 4.4x |
| Sun, 27 Mar 2022 | kr60.7b | kr11.8b | kr746.3m | 53.5x | 81.3x | 5.1x |
| Tue, 22 Feb 2022 | kr49.0b | kr11.4b | kr784.8m | 41.6x | 62.4x | 4.3x |
| Thu, 20 Jan 2022 | kr67.7b | kr10.8b | kr786.3m | 46.6x | 86.1x | 6.3x |
| Sat, 18 Dec 2021 | kr79.5b | kr10.8b | kr786.3m | 51.5x | 101.1x | 7.4x |
| Mon, 15 Nov 2021 | kr87.9b | kr10.8b | kr788.8m | 53.4x | 111.5x | 8.1x |
| Wed, 13 Oct 2021 | kr86.2b | kr9.9b | kr853.6m | 49.9x | 101x | 8.7x |
| Fri, 10 Sep 2021 | kr102.5b | kr9.9b | kr853.6m | 58.5x | 120.1x | 10.4x |
| Sun, 08 Aug 2021 | kr91.2b | kr9.9b | kr853.6m | 50.1x | 106.8x | 9.2x |
| Sat, 01 May 2021 | kr75.7b | kr8.5b | kr852.0m | 47.3x | 88.8x | 8.9x |
Price to Earnings Ratio
88.8x
Current Industry PE
- Investors are pessimistic on the Swedish Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 4.3x is higher than the industry's current PS ratio of 2.3x.
Past Earnings Growth
- Total earnings for the Life Sciences Tools and Services industry have declined over the last three years, with the industry now making a loss overall.
- Meanwhile revenues have grown 24% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Comparison
How does Swedish Clinical Research and Equipment compare with similar industries?
| SE Market | -1.61% | |
| Healthcare | -2.48% | |
| Life Sciences | -4.32% | |
| Clinical Research and Equipment | -4.32% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| BICO BICO Group | kr47.72 | 12.5% +kr374.0m | -9.4% | PS1.4x | |
| MCAP MedCap | kr418.00 | 1.8% +kr111.1m | 56.3% | PE35.9x | |
| ATANA Attana | kr0.083 | 16.9% +kr4.7m | -55.4% | PS4.7x | |
| AROC AroCell | kr0.38 | 5.3% +kr4.4m | -41.3% | PS2x | |
| ALPH AlphaHelix Molecular Diagnostics | kr0.35 | 21.8% +kr3.9m | -47.7% | PS0.8x |
